Happy Holidays and New year from the EMDB! Please be advised that the EMDB team will be operating at reduced capacity between December 15th - January 12th. With this in mind we would ask that you be prepared for longer reply times through both our helpdesk system and the OneDep deposition system. well done on a productive 2025, wishing you all the best and we will see you in 2026!

EMD-50615

Single-particle
5.3 Å
EMD-50615
3D View Gallery
Deposition: 11/06/2024
Map released: 09/10/2024
Last modified: 13/11/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-50615
Download
3D volume (map.gz) Experimental metadata (xml) Experimental Metadata (cif.gz)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
Map and PDB model 9fo3 summary report (pdf.gz) Map and 9fo3 FULL report (pdf.gz)
EMICSS annotations (xml)

Structure of a gp140 SpyTag-SpyCatcher mi3 nanoparticle including mi3 density only.

EMD-50615

Single-particle
5.3 Å
EMD-50615
3D View Gallery
Deposition: 11/06/2024
Map released: 09/10/2024
Last modified: 13/11/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Thermotoga maritima
Sample: CAP255 gp140 SpyTag-SpyCatcher mi3 nanoparticle
Fitted models: 9fo3

Deposition Authors: Woodward JD , Malebo K , Chapman R
Development of a Two-Component Nanoparticle Vaccine Displaying an HIV-1 Envelope Glycoprotein that Elicits Tier 2 Neutralising Antibodies.
Malebo K , Woodward J, Ximba P, Mkhize Q , Cingo S , Moyo-Gwete T , Moore PL, Williamson AL , Chapman R
(2024) Vaccines (Basel) , 12
PUBMED: 39340093
DOI: doi:10.3390/vaccines12091063
ISSN: 2076-393X